<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>同写意 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-18T20:32:51+08:00</updated>
  <subtitle>一个以新药创制为核心，汇集国内一流研发精英的大型交流与价值分享平台。“同筑技术人生路，写意中国新药魂”是同写意的初衷与愿景。秉承汇集“一线、一流”，讲求“实用、实在、时效”的原则</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>写意报告丨临床开发的重中之重—适应症的选择策略</title>
    <updated>2021-01-18T18:56:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/b_c-BtNd83H91mLDk6Jf_g</id>
    <link href="https://mp.weixin.qq.com/s/b_c-BtNd83H91mLDk6Jf_g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意发布丨丹诺医药与强生公司合作研发新药产品</title>
    <updated>2021-01-18T18:56:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/IjZlryt5kVjgy-YhRO6ZBQ</id>
    <link href="https://mp.weixin.qq.com/s/IjZlryt5kVjgy-YhRO6ZBQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全面落实MAH制度，还有哪些挑战？</title>
    <updated>2021-01-18T18:56:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/4CsXEqUQK3qNeVgH_khAWg</id>
    <link href="https://mp.weixin.qq.com/s/4CsXEqUQK3qNeVgH_khAWg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>两会“医药”之声｜第二届（2021）重庆市医药界人大代表政协委员座谈会成功举办！</title>
    <updated>2021-01-18T18:56:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/GlhpO2AqoB5kQgV5OG5HvA</id>
    <link href="https://mp.weixin.qq.com/s/GlhpO2AqoB5kQgV5OG5HvA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意报告丨创响生物王健：投融资的陷阱与谎言</title>
    <updated>2021-01-17T20:29:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/-Vcckl5uNKv_qzx6uOtjVw</id>
    <link href="https://mp.weixin.qq.com/s/-Vcckl5uNKv_qzx6uOtjVw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年中国获批新药的高光时刻</title>
    <updated>2021-01-17T20:29:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/MlxNCwZ-0iow20Z-sLAZKw</id>
    <link href="https://mp.weixin.qq.com/s/MlxNCwZ-0iow20Z-sLAZKw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意报告丨俞金泉：利用ADCC增强的技术开发治疗癌症的抗体药物</title>
    <updated>2021-01-17T20:29:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/60I_i24gX1T60-tnw4h0yw</id>
    <link href="https://mp.weixin.qq.com/s/60I_i24gX1T60-tnw4h0yw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新法规下，境外生产化药中国注册有这些路径可以走</title>
    <updated>2021-01-17T20:29:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/9p3ws8xMsQIZoMrhaJ9ZRA</id>
    <link href="https://mp.weixin.qq.com/s/9p3ws8xMsQIZoMrhaJ9ZRA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>杰克说药丨美国乡下白人的悲歌(下) —阿片类药物滥用的故事</title>
    <updated>2021-01-16T21:56:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/gGupWzjQCV9xIUFkL8oFzg</id>
    <link href="https://mp.weixin.qq.com/s/gGupWzjQCV9xIUFkL8oFzg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>华烨博士：布局解决临床痛点药物，填补治疗空白！</title>
    <updated>2021-01-16T21:56:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/aA80apGIEDyaZfq2GkOXTA</id>
    <link href="https://mp.weixin.qq.com/s/aA80apGIEDyaZfq2GkOXTA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CXO众神：虎与龙的战斗</title>
    <updated>2021-01-16T21:56:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/4IAnMRBfbbxiMWRjFTyTag</id>
    <link href="https://mp.weixin.qq.com/s/4IAnMRBfbbxiMWRjFTyTag" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>美国如何成为世界创新药的中心？</title>
    <updated>2021-01-16T21:56:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/J_MP9D5BHb0ef9yRVzhdBg</id>
    <link href="https://mp.weixin.qq.com/s/J_MP9D5BHb0ef9yRVzhdBg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>瑞德西韦去年卖出28亿美元，吉利德押中宝了吗？</title>
    <updated>2021-01-15T18:59:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/8dHBWiBb2-Zv1AX5zY-5Fw</id>
    <link href="https://mp.weixin.qq.com/s/8dHBWiBb2-Zv1AX5zY-5Fw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意会员丨中晟全肽：重塑多肽新药发现平台</title>
    <updated>2021-01-15T18:59:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/AFlP4-S8OMZS4JGj_4-17g</id>
    <link href="https://mp.weixin.qq.com/s/AFlP4-S8OMZS4JGj_4-17g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>美国如何成为世界创新药的中心？</title>
    <updated>2021-01-15T18:59:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/dpn95x6GjpSnAPZhEW00AQ</id>
    <link href="https://mp.weixin.qq.com/s/dpn95x6GjpSnAPZhEW00AQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国信医药董事长陈永清：深耕医药创新生态圈，坚守“荷花定律”厚积薄发</title>
    <updated>2021-01-15T18:59:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/NqXQ4wcPtbna86EiaF35fg</id>
    <link href="https://mp.weixin.qq.com/s/NqXQ4wcPtbna86EiaF35fg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意发布丨Cytiva向龙沙交付模块化生物制品工厂</title>
    <updated>2021-01-14T19:05:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/QQkYkMFRQIOLlk2ocHHuKA</id>
    <link href="https://mp.weixin.qq.com/s/QQkYkMFRQIOLlk2ocHHuKA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意发布丨中国首个自主创新微球制剂瑞欣妥在华获批</title>
    <updated>2021-01-14T19:05:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/LIN5mp1uPHMhjGoR52QvNw</id>
    <link href="https://mp.weixin.qq.com/s/LIN5mp1uPHMhjGoR52QvNw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意发布丨润东医药与丽珠医药集团股份有限公司达成战略合作</title>
    <updated>2021-01-14T19:05:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/ZlnhlcpVYldf6T3A_COWVg</id>
    <link href="https://mp.weixin.qq.com/s/ZlnhlcpVYldf6T3A_COWVg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意发布丨百济神州PD-1正式获批一线鳞状NSCLC适应症</title>
    <updated>2021-01-14T19:05:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/xwlt6inaV_e2BzbdJuxEbA</id>
    <link href="https://mp.weixin.qq.com/s/xwlt6inaV_e2BzbdJuxEbA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>